Literature DB >> 29201879

Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion.

Jo Raskin1, Annelies Janssens1, Jan P Van Meerbeeck1.   

Abstract

Entities:  

Year:  2017        PMID： 29201879      PMCID： PMC5690971          DOI： 10.21037/atm.2017.08.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Authors:  A Brunelli; A Charloux; C T Bolliger; G Rocco; J-P Sculier; G Varela; M Licker; M K Ferguson; C Faivre-Finn; R M Huber; E M Clini; T Win; D De Ruysscher; L Goldman
Journal:  Eur Respir J       Date:  2009-07       Impact factor: 16.671

2.  Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment.

Authors:  Wendy Hopmans; Laura Zwaan; Suresh Senan; Ineke van der Wulp; Olga C Damman; Koen J Hartemink; Egbert F Smit; Danielle R M Timmermans
Journal:  Radiother Oncol       Date:  2015-05-30       Impact factor: 6.280

3.  Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.

Authors:  A G Pallis; C Gridelli; U Wedding; C Faivre-Finn; G Veronesi; M Jaklitsch; A Luciani; M O'Brien
Journal:  Ann Oncol       Date:  2014-03-16       Impact factor: 32.976

4.  Recalibration of the revised cardiac risk index in lung resection candidates.

Authors:  Alessandro Brunelli; Gonzalo Varela; Michele Salati; Marcelo F Jimenez; Cecilia Pompili; Nuria Novoa; Armando Sabbatini
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

Review 6.  Segmental resection spares pulmonary function in patients with stage I lung cancer.

Authors:  Robert J Keenan; Rodney J Landreneau; Richard H Maley; Deepak Singh; Robin Macherey; Susan Bartley; Tibetha Santucci
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

7.  Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.

Authors:  Anand Shah; Stephen M Hahn; Robert L Stetson; Joseph S Friedberg; Taine T V Pechet; David J Sher
Journal:  Cancer       Date:  2013-05-29       Impact factor: 6.860

8.  Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).

Authors:  Traves Crabtree; Varun Puri; Robert Timmerman; Hiran Fernando; Jeffrey Bradley; Paul A Decker; Rebecca Paulus; Joe B Putnum; Damian E Dupuy; Bryan Meyers
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-20       Impact factor: 5.209

9.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.